Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS)

Coronary Artery Calcium for Cardiovascular Risk Estimation in Patients With Cancer

“…These observations are in line with a recent expert consensus document from the Society of Cardiac Computed Tomography, which recommends reporting at least a statement on the presence or absence of CAC on noncardiac chest CT scan for cancer imaging and ideally also add CAC quantification using either semiquantitative methods, such as Coronary Artery Disease Reporting and Data System or CAC score. 6,20 Furthermore, this study reinforces the utility of CAC measurements for the introduction of preventive therapies (eg, statins) as recommended in the Society of Cardiovascular Computed Tomography expert consensus. 20 Cardiovascular diseases and most cancer types, apart from few exceptions, develop around the same age and are associated due to their shared risk factors, therefore, conclusions of this study underline the notion of considering patients with cancer in a more holistic approach.…”

“…6,20 Furthermore, this study reinforces the utility of CAC measurements for the introduction of preventive therapies (eg, statins) as recommended in the Society of Cardiovascular Computed Tomography expert consensus. 20 Cardiovascular diseases and most cancer types, apart from few exceptions, develop around the same age and are associated due to their shared risk factors, therefore, conclusions of this study underline the notion of considering patients with cancer in a more holistic approach.…”

Coronary artery calcium: from risk prediction to treatment allocation and clinical trials

“…CAC-DRS is simple to score and an increasing CAC-DRS has a graded relationship with higher CVD risk 21. In particular, there is an especially high utility for measuring CAC among patients undergoing CT of the chest for lung cancer screening in whom there was a 45% prevalence of CAC ≥100 and the SCCT recommends reporting CAC for non-cardiac CT of the chest for patients undergoing cancer staging or surveillance 22 23…”

Editorial: Novel mechanisms, imaging approaches, and management strategies for anthracycline-induced cardiotoxicity

“…Feher et al provide a review of novel cardiac CT methods for the assessment of AIC. Cardiac CT has an increasing number of indications in cardiovascular medicine and cardio-oncology ( 7 ). Beyond the evaluation of coronary arteries and cardiac function, the authors develop new CT techniques including myocardial deformation, extracellular volume measurement, coronary vasoreactivity, determination of microvascular dysfunction, and even nanoparticle-based molecular imaging, highlighting their potential applicability in AIC.…”